The largest database of trusted experimental protocols

7 protocols using cnbr sepharose 4b

1

Purification of Anti-CHO-rPvs48/45 IgG

Check if the same lab product or an alternative is used in the 5 most similar protocols
A serum pool collected from TZ adult donors with high anti- CHO-rPvs48/45 antibody titers was used for IgG purification, as described previously [72 (link), 73 (link)]. To prepare the antigen-Sepharose conjugate, CNBr-sepharose 4B (Amersham Bioscience AB, Uppsala, Sweden) was activated with 1 mM HCl. Then, 5 mg of the CHO-rPvs48/45 protein was dissolved in 1 mL of coupling buffer (0.1 M NaHCO3 containing 0.5 M NaCl, pH 8.0). The sera were diluted 5-fold with PBS (1x) containing 0.5 M sodium chloride and were mixed with the antigen-sepharose conjugate and stirred O/N gently at 4°C. The antigen-sepharose beads were then washed with 5 mL of TRIS (20 mM containing 0.5 M NaCl, pH 8.0) and then with 5 mL of TRIS (20 mM, pH 8.0). The bound antibody was eluted with a solution containing glycine (0.1 M, pH 2.5). The fractions (F1, F2, F3) were collected in TRIS solution (1 M, pH 8.0) to instantly neutralize the solutions before dialyzing them against phosphate buffer (0.1M, pH 7.0). The antibody (IgG) concentration of each fraction was determined by the absorbance of the solution at 280 nm [72 (link), 73 (link)]. In addition, ELISA was used to determine the recognition of rPvs48/45 by each of the purified antibody fractions.
+ Open protocol
+ Expand
2

Mapping Phytochemical Signaling Cascades

Check if the same lab product or an alternative is used in the 5 most similar protocols
6,7,4'-THIF was obtained from Chromadex™ (Irvine, CA, USA), and Dulbecco’s modified eagle medium (DMEM) and MMP-1 antibody were purchased from Thermo Fisher Scientific (San José, CA, USA). Medium 199 (M199) and daidzein were purchased from Sigma-Aldrich (St. Louis, MO, USA), and fetal bovine serum (FBS) was purchased from Gemini Bio-Products (Calabasas, CA, USA). CNBr-Sepharose 4B, [γ-32P]-ATP and the chemiluminescence detection kit were obtained from Amersham Pharmacia Biotech (Piscataway, NJ, USA). The protein assay kit was purchased from Bio-Rad Laboratories (Hercules, CA, USA). MTS solution was from Promega (Madison, WI, USA). Penicillin/streptomycin was purchased from Invitrogen (Grand Island, NY, USA). Primary antibodies recognizing phosphorylated MEK (Ser217/221), total MEK, phosphorylated SEK1/MKK4 (MKK4, Ser257/Thr261), phosphorylated MKK3 (Ser189)/6 (Ser207), total MKK3, phosphorylated p38 (Tyr180/182), total p38 and PKCα were purchased from Cell Signaling Technology (Danvers, MA). Antibodies against phosphorylated-ERKs (Tyr204), total ERKs, ERK2, total MKK4, phosphorylated JNK (Thr183/Tyr185), total JNK, JNK2 and phosphorylated PKCα (Ser657) were obtained from Santa Cruz Biotechnology (Santa Cruz, CA, USA). Active PKCα and PKCδ proteins were purchased from Millipore (Bedford, MA, USA).
+ Open protocol
+ Expand
3

Eupafolin Molecular Assay Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
Eupafolin (> 95% purity) was purchased from Indofine (Hillsborough, NJ). Chemical reagents for molecular biology and buffer preparation, including Tris, NaCl, and SDS were obtained from Sigma-Aldrich (St. Louis, MO). Eagle’s MEM was from Invitrogen (Carlsbad, CA). Glutathione-Sepharose 4B and CNBr-Sepharose 4B were purchased from Amersham Pharmacia Biotech (Piscataway, NJ). The luciferase assay substrate was obtained from Promega (Madison, WI). Antibodies were from Santa Cruz Biotechnology (Santa Cruz, CA), Cell Signaling Technology (Beverly, MA), or Upstate Biotechnology, Inc. (Charlottesville, VA).
+ Open protocol
+ Expand
4

Characterization of Elk-1 and DNMT1 Regulation

Check if the same lab product or an alternative is used in the 5 most similar protocols
The antibodies against ERK1, p38, Elk1 and phosphor-ERK were obtained from Santa Cruz Biotechnology. The antibody against DNMT1 was from Epitomics. The antibodies against phosphor-Elk1 (Ser383), Akt, and p44/42 MAP kinase assay kit were purchased from Cell Signaling Technology. CNBr-Sepharose 4B were purchased from Amersham Pharmacia Biotech. PD98059 was obtained from Calbiochem.
The coding region of human Elk-1 was cloned by PCR and inserted into pcDNA3.1 vector to construct the eukaryotic expression Elk-1 plasmid pcDNA3.1-Elk1. The 2193 bp dnmt1 promoter fragment was inserted into pGL3-Basic vector (Promega) and the plasmid was designated as pGL3-dnmt1. The full-length coding region of MEK1 with mutations(S218,S222) or MEK2 with mutations(S222,S226) was inserted into GV141 vector by XhoI and KpnI to construct the eukaryotic expression constitutively active MEK1 and MEK2 plasmids, respectively.
Grifolin (2-trans, trans-farnesyl-5-methylresorcinol) was provided by Kunming Institute of Botany, the Chinese Academy of Sciences (purity > 99%, HPLC analysis). Dimethyl sulphoxide (DMSO, Sigma) was used to dissolve grifolin. The final concentration of DMSO in the culture media was kept less than 0.1% v/v which had no significant effect on the cell growth.
+ Open protocol
+ Expand
5

Signaling Pathway Characterization Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
RPMI 1640 medium, basal medium eagle (BME), gentamicin, and L-glutamine were purchased from Invitrogen (Carlsbad, CA, USA). Antibodies against p-Akt (S473), p-PTEN (S380), PTEN, p-ERK1/2 (T202/Y204), ERK, p-p90RSK (T359/S363), p90RSK, p-JNK1/2 (T183/Y185), JNK1/2, p-GSK3β (S9), GSK3β, cyclin D1, CDK4, cyclin E, p-CDK2 (Y15), CDK2, and p-RB (S780) were obtained from Cell Signaling Biotechnology (Beverly, MA, USA). Antibodies against p85 and p110 were obtained from Santa Cruz Biotechnology (Santa Cruz, CA, USA). The antibody against β-actin was obtained from Sigma-Aldrich (St. Louis, MO, USA) and the active PI3K protein was obtained from EMD Millipore (Billerica, MA, USA), CNBr-Sepharose 4B, glutathione-Sepharose 4B, [γ-32P] ATP and the chemiluminescence detection kit were purchased from Amersham Pharmacia Biotech (Piscataway, NJ, USA), and the protein assay kit was from Bio-Rad Laboratories (Hercules, CA, USA).
+ Open protocol
+ Expand
6

Purification of Anti-P27A IgG Antibodies

Check if the same lab product or an alternative is used in the 5 most similar protocols
P27A-sepharose conjugate was prepared with 16 mg of P27A mixed with 2.5 g of CNBr-Sepharose 4B (Amersham Bioscience AB, S-Uppsala) according to the manufacturer's protocol. Five to 7 mL of D84 plasma diluted 1:5 in PBS 0.5 M NaCl was mixed with the P27A-sepharose conjugate and stirred gently overnight at 4°C. After centrifugation, washing and transferring the beads into a syringe, bound antibodies were eluted with glycine (0.1 M, pH 2.5). The collected fractions were instantly neutralized with PBS (10x, pH 7.4), and their protein concentration was determined by the absorbance at 280 nm and anti-P27A IgG by ELISA. Fractions of interest were pooled. Total IgG from D0 plasma were purified by affinity chromatography on protein G using the manufacturer's protocol (GammaBind™ Plus Sepharose™, GE Healthcare, S-Uppsala).
+ Open protocol
+ Expand
7

Recombinant ADAMTS13 Production and Antibody Purification

Check if the same lab product or an alternative is used in the 5 most similar protocols
Recombinant full length ADAMTS13 was produced in stable transfected HEK293 cells and purified as described previously.9 (link) Concentration of purified ADAMTS13 was determined using the Bradford assay. Lipopolysaccharide (LPS) was obtained from Sigma-Aldrich (St. Louis, USA). The hybridoma producing the HLA-DQ-specific antibody (SPV-L3)22 (link) was a kind gift from Prof. dr. H. Spits (Academic Medical Center, Amsterdam, the Netherlands). The hybridoma producing the HLA-DR-specific monoclonal antibody (L243) was purchased from ATCC (Wesel, Germany). Antibodies were purified from culture supernatant via protein A Sepharose (GE Healthcare) and coupled to CNBr Sepharose 4B at a final concentration of 2 mg/mL (Amersham Biosciences, Buckinghamshire, UK).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!

  Request a quote for « Cnbr sepharose 4b »